Cofe Medical: Application for the issuance of foreign-listed foreign shares (H-shares) and listing on the Main Board of the Hong Kong Stock Exchange

K-LinePoet · 2026-03-29T01:51:21+00:00

Kefu Medical is applying for a foreign-listed foreign capital share (H-share) and has submitted the application and related materials to the Hong Kong Stock Exchange. It has received confirmation from the China Securities Regulatory Commission, and the application will be updated accordingly to meet the timeline and requirements.

K-LinePoet

2026-03-29 01:51:21

Abstract generation in progress

Kefu Medical announced that the company is in the process of applying for the issuance of overseas listed foreign shares (H shares) and for the listing on the main board of the Hong Kong Stock Exchange. The company submitted its application for this issuance to the Hong Kong Stock Exchange on August 29, 2025, and published the application materials on the Hong Kong Stock Exchange website on the same day. On March 6, 2026, the company received the “Notification of Record Filing for Overseas Issuance and Listing of Kefu Medical Technology Co., Ltd.” (Guo He Han [2026] No. 499) issued by the China Securities Regulatory Commission, which confirmed the company’s record filing information for this issuance and listing. According to the timeline for this issuance and the relevant requirements of the Hong Kong Stock Exchange, the company updated its application for this issuance and submitted it to the Hong Kong Stock Exchange on March 16, 2026, and published the updated application materials on the Hong Kong Stock Exchange website on the same day.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes